Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Disruptions in access to antiretroviral treatment due to the COVID-19 pandemic could lead to a major setback in combating HIV.
Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.
International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk.
Calling all U.S. cisgender gay and bi men and trans and gender nonconforming people at risk for the virus.
That’s enough to treat 1,000 immigrants for one year.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Researchers provided an initial Truvada prescription to eligible gay and bi men and trans women at their first appointment.
Researchers analyzed data from 42 HIV centers in 11 Latin American nations.
Advocates say the government hasn’t provided data on HIV-positive refugees. Here’s why they want those numbers.
San Francisco and Mexico City host competing conferences.
It’s planned by activists who cannot or will not attend the San Francisco gathering because of U.S. discriminatory policies.
Listen to personal tales from the global urban AIDS response, including reports from five U.S. cities.
The program takes place June 3 through 6 in Indianapolis, but the main sessions will be streamed live on Facebook.
“You are sending me to my death!”
The high proportion of individuals starting treatment with drug resistance already warrants changing the recommended first-line therapy.
But the median CD4 count at treatment start is below 350, which means work is needed to catch up to World Health Organization guidelines.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.